BioTelemetry, Inc. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 10 rows, 10 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-02-09: Reporting owner Getz Heather C; Form 4; Security Performance Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-02-09: Reporting owner Getz Heather C; Form 4; Security Performance Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-02-09: Reporting owner Getz Heather C; Form 4; Security Performance Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2021-02-09: Reporting owner Broadway Fred; Form 4; Security Performance Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,977 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,987 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Getz Heather C Officer (EVP, CFO & CAO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,426 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,635 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,987 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Broadway Fred Officer (President BioTel Heart) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,935 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Wadhwa Manish Officer (SVP & CMO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,754 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,834 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,946 0 owned after | $72.00 | 2021-02-11 | |
| 2021-02-09 | Capper Joseph H Director, Officer (President & CEO) | 4 | Performance Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,762 0 owned after | $72.00 | 2021-02-11 |